Jpmorgan Chase & CO Procept Bio Robotics Corp Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 812,366 shares of PRCT stock, worth $59.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

812,366

Previous 896,747 9.41%

Holding current value

$59.7 Million

Previous $54.8 Million 18.79%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 26, 2024	SELL	$56.31 - $84.99 $4.75 Million - $7.17 Million	-84,381 Reduced 9.41%	812,366 $65.1 Million
Q3 2024 Nov 08, 2024	SELL	$56.31 - $84.99 $4.75 Million - $7.17 Million	-84,381 Reduced 9.41%	812,366 $65.1 Million
Q2 2024 Dec 26, 2024	BUY	$45.73 - $69.19 $3.86 Million - $5.84 Million	84,381 Added 10.39%	896,747 $54.8 Million
Q2 2024 Aug 12, 2024	BUY	$45.73 - $69.19 $37.7 Million - $57 Million	823,558 Added 1125.25%	896,747 $54.8 Million
Q1 2024 Dec 26, 2024	SELL	$40.38 - $50.75 $29.8 Million - $37.5 Million	-739,177 Reduced 90.99%	73,189 $3.62 Million
Q1 2024 May 10, 2024	SELL	$40.38 - $50.75 $1.9 Million - $2.39 Million	-47,058 Reduced 39.13%	73,189 $3.62 Million
Q4 2023 Dec 26, 2024	SELL	$24.89 - $43.41 $17.2 Million - $30 Million	-692,119 Reduced 85.2%	120,247 $5.04 Million
Q4 2023 Feb 12, 2024	SELL	$24.89 - $43.41 $64,913 - $113,213	-2,608 Reduced 2.12%	120,247 $5.04 Million
Q3 2023 Nov 14, 2023	BUY	$30.02 - $38.81 $26,897 - $34,773	896 Added 0.73%	122,855 $4.03 Million
Q2 2023 Aug 11, 2023	BUY	$26.7 - $37.02 $1.09 Million - $1.51 Million	40,843 Added 50.35%	121,959 $4.31 Million
Q1 2023 May 18, 2023	BUY	$26.64 - $39.74 $954,884 - $1.42 Million	35,844 Added 79.17%	81,116 $2.3 Million
Q1 2023 May 11, 2023	BUY	$26.64 - $39.74 $421,844 - $629,282	15,835 Added 53.79%	45,272 $1.29 Million
Q4 2022 Feb 13, 2023	BUY	$38.78 - $46.78 $124,561 - $150,257	3,212 Added 12.25%	29,437 $1.22 Million
Q3 2022 Nov 14, 2022	SELL	$30.9 - $50.65 $1.21 Million - $1.98 Million	-39,189 Reduced 59.91%	26,225 $1.09 Million
Q2 2022 Aug 11, 2022	BUY	$29.23 - $44.45 $1.76 Million - $2.67 Million	60,061 Added 1122.01%	65,414 $2.14 Million
Q1 2022 May 11, 2022	BUY	$16.89 - $35.74 $13,934 - $29,485	825 Added 18.22%	5,353 $188,000
Q4 2021 Feb 10, 2022	BUY	$24.6 - $46.29 $111,388 - $209,601	4,528 New	4,528 $113,000

Others Institutions Holding PRCT

# of Institutions

272

Shares Held

38.9M

Call Options Held

262K

Put Options Held

257K

View Full List

About PROCEPT BioRobotics Corp

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $3.28B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

More about PRCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Procept Bio Robotics Corp Transaction History